annual EBITDA:
-$109.58M+$67.87M(+38.25%)Summary
- As of today (September 18, 2025), NVCR annual EBITDA is -$109.58 million, with the most recent change of +$67.87 million (+38.25%) on December 31, 2024.
- During the last 3 years, NVCR annual EBITDA has fallen by -$71.20 million (-185.49%).
- NVCR annual EBITDA is now -344.42% below its all-time high of $44.83 million, reached on December 31, 2020.
Performance
NVCR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$36.08M-$1.54M(-4.45%)Summary
- As of today (September 18, 2025), NVCR quarterly EBITDA is -$36.08 million, with the most recent change of -$1.54 million (-4.45%) on June 30, 2025.
- Over the past year, NVCR quarterly EBITDA has dropped by -$5.33 million (-17.33%).
- NVCR quarterly EBITDA is now -309.63% below its all-time high of $17.21 million, reached on September 30, 2020.
Performance
NVCR quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$159.50M-$5.33M(-3.46%)Summary
- As of today (September 18, 2025), NVCR TTM EBITDA is -$159.50 million, with the most recent change of -$5.33 million (-3.46%) on June 30, 2025.
- Over the past year, NVCR TTM EBITDA has increased by +$5.65 million (+3.42%).
- NVCR TTM EBITDA is now -468.13% below its all-time high of $43.33 million, reached on March 31, 2021.
Performance
NVCR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NVCR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.3% | -17.3% | +3.4% |
| 3 y3 years | -185.5% | -95.3% | -269.0% |
| 5 y5 years | -911.1% | -489.2% | -1085.6% |
NVCR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -185.5% | +38.3% | -95.3% | +39.8% | -269.0% | +25.9% |
| 5 y | 5-year | -344.4% | +38.3% | -309.6% | +39.8% | -468.1% | +25.9% |
| alltime | all time | -344.4% | +38.3% | -309.6% | +39.8% | -468.1% | +25.9% |
NVCR EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$36.08M(+4.4%) | -$159.50M(+3.5%) |
| Mar 2025 | - | -$34.54M(-41.7%) | -$154.17M(-1.4%) |
| Dec 2024 | -$109.58M(-38.2%) | -$59.25M(+99.9%) | -$156.30M(+12.2%) |
| Sep 2024 | - | -$29.63M(-3.6%) | -$139.34M(-15.6%) |
| Jun 2024 | - | -$30.75M(-16.2%) | -$165.14M(-15.0%) |
| Mar 2024 | - | -$36.67M(-13.3%) | -$194.33M(-9.7%) |
| Dec 2023 | -$177.45M(+161.4%) | -$42.28M(-23.7%) | -$215.19M(+0.9%) |
| Sep 2023 | - | -$55.44M(-7.5%) | -$213.19M(+18.6%) |
| Jun 2023 | - | -$59.94M(+4.2%) | -$179.70M(+30.0%) |
| Mar 2023 | - | -$57.53M(+42.8%) | -$138.23M(+75.2%) |
| Dec 2022 | -$67.89M(+76.9%) | -$40.28M(+83.5%) | -$78.90M(+32.9%) |
| Sep 2022 | - | -$21.95M(+18.8%) | -$59.35M(+37.3%) |
| Jun 2022 | - | -$18.47M(-1124.1%) | -$43.22M(+25.1%) |
| Mar 2022 | - | $1.80M(-108.7%) | -$34.56M(+1.4%) |
| Dec 2021 | -$38.38M(-185.6%) | -$20.73M(+256.3%) | -$34.08M(-2907.4%) |
| Sep 2021 | - | -$5.82M(-40.7%) | $1.21M(-95.0%) |
| Jun 2021 | - | -$9.81M(-530.1%) | $24.24M(-44.0%) |
| Mar 2021 | - | $2.28M(-84.3%) | $43.33M(+9.5%) |
| Dec 2020 | $44.83M(+231.9%) | $14.56M(-15.4%) | $39.55M(+43.3%) |
| Sep 2020 | - | $17.21M(+85.7%) | $27.61M(+70.6%) |
| Jun 2020 | - | $9.27M(-720.8%) | $16.18M(+58.0%) |
| Mar 2020 | - | -$1.49M(-157.0%) | $10.24M(+35.7%) |
| Dec 2019 | $13.51M | $2.62M(-54.7%) | $7.54M(-592.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $5.79M(+73.9%) | -$1.53M(-85.1%) |
| Jun 2019 | - | $3.33M(-179.4%) | -$10.26M(-44.2%) |
| Mar 2019 | - | -$4.19M(-35.1%) | -$18.38M(-25.5%) |
| Dec 2018 | -$20.67M(-32.4%) | -$6.46M(+120.1%) | -$24.67M(+20.0%) |
| Sep 2018 | - | -$2.94M(-38.8%) | -$20.56M(-4.3%) |
| Jun 2018 | - | -$4.80M(-54.2%) | -$21.49M(-29.3%) |
| Mar 2018 | - | -$10.47M(+345.1%) | -$30.41M(-3.9%) |
| Dec 2017 | -$30.56M(-72.2%) | -$2.35M(-39.1%) | -$31.65M(-30.6%) |
| Sep 2017 | - | -$3.87M(-71.8%) | -$45.59M(-33.4%) |
| Jun 2017 | - | -$13.72M(+17.1%) | -$68.43M(-18.7%) |
| Mar 2017 | - | -$11.71M(-28.1%) | -$84.13M(-18.5%) |
| Dec 2016 | -$109.88M(+8.1%) | -$16.29M(-39.0%) | -$103.25M(-11.3%) |
| Sep 2016 | - | -$26.71M(-9.2%) | -$116.42M(+3.0%) |
| Jun 2016 | - | -$29.42M(-4.6%) | -$113.05M(+2.5%) |
| Mar 2016 | - | -$30.84M(+4.7%) | -$110.25M(+9.4%) |
| Dec 2015 | -$101.62M(+29.8%) | -$29.45M(+26.2%) | -$100.81M(+41.3%) |
| Sep 2015 | - | -$23.34M(-12.3%) | -$71.35M(+48.6%) |
| Jun 2015 | - | -$26.62M(+24.4%) | -$48.01M(+13.9%) |
| Mar 2015 | - | -$21.39M(+3.1%) | -$42.14M(+10.1%) |
| Dec 2014 | -$78.30M(+14.1%) | - | - |
| Jun 2014 | - | -$20.75M(+18.3%) | -$38.29M(+118.3%) |
| Mar 2014 | - | -$17.54M | -$17.54M |
| Dec 2013 | -$68.64M | - | - |
FAQ
- What is NovoCure Limited annual EBITDA?
- What is the all time high annual EBITDA for NovoCure Limited?
- What is NovoCure Limited annual EBITDA year-on-year change?
- What is NovoCure Limited quarterly EBITDA?
- What is the all time high quarterly EBITDA for NovoCure Limited?
- What is NovoCure Limited quarterly EBITDA year-on-year change?
- What is NovoCure Limited TTM EBITDA?
- What is the all time high TTM EBITDA for NovoCure Limited?
- What is NovoCure Limited TTM EBITDA year-on-year change?
What is NovoCure Limited annual EBITDA?
The current annual EBITDA of NVCR is -$109.58M
What is the all time high annual EBITDA for NovoCure Limited?
NovoCure Limited all-time high annual EBITDA is $44.83M
What is NovoCure Limited annual EBITDA year-on-year change?
Over the past year, NVCR annual EBITDA has changed by +$67.87M (+38.25%)
What is NovoCure Limited quarterly EBITDA?
The current quarterly EBITDA of NVCR is -$36.08M
What is the all time high quarterly EBITDA for NovoCure Limited?
NovoCure Limited all-time high quarterly EBITDA is $17.21M
What is NovoCure Limited quarterly EBITDA year-on-year change?
Over the past year, NVCR quarterly EBITDA has changed by -$5.33M (-17.33%)
What is NovoCure Limited TTM EBITDA?
The current TTM EBITDA of NVCR is -$159.50M
What is the all time high TTM EBITDA for NovoCure Limited?
NovoCure Limited all-time high TTM EBITDA is $43.33M
What is NovoCure Limited TTM EBITDA year-on-year change?
Over the past year, NVCR TTM EBITDA has changed by +$5.65M (+3.42%)